Variable | Cancer-specific Survival | Overall survival | ||||||
---|---|---|---|---|---|---|---|---|
 | Univariate | P value | Multivariate | P value | Univariate | P value | Multivariate | P value |
 | HR (95% CI) |  | HR (95% CI) |  | HR (95% CI) |  | HR (95% CI) |  |
Age | ||||||||
  ≤ 56 | 1 |  | 1 |  | 1 |  | 1 |  |
  > 56 | 1.46 (1.3–1.64) | <.0001 | 1.19 (1.05–1.34) | 0.0054 | 1.99 (1.8–2.19) | <.0001 | 1.61 (1.45–1.78) | <.0001 |
Gender | ||||||||
 Male | 1 |  |  |  | 1 |  | 1 |  |
 Female | 1.06 (0.94–1.19) | 0.3459 |  |  | 0.92 (0.84–1.01) | 0.0715 | 0.82 (0.74–0.9) | <.0001 |
Marital status | ||||||||
 Married | 1 |  | 1 |  | 1 |  | 1 |  |
 Unmarrieda | 1.04 (0.92–1.18) | 0.507 | 1.24 (1.09–1.4) | 0.0008 | 1.17 (1.07–1.29) | 0.0011 | 1.35 (1.22–1.49) | <.0001 |
 Unknown | 0.78 (0.58–1.06) | 0.1106 | 1.3 (0.96–1.77) | 0.092 | 0.84 (0.66–1.07) | 0.1632 | 1.28 (1–1.63) | 0.0501 |
Race | ||||||||
 African American | 1 |  | 1 |  | 1 |  | 1 |  |
 White | 0.72 (0.6–0.85) | 0.0002 | 0.75 (0.62–0.9) | 0.0017 | 0.75 (0.65–0.86) | <.0001 | 0.82 (0.71–0.95) | 0.0068 |
 Other | 0.9 (0.69–1.18) | 0.447 | 0.77 (0.58–1.02) | 0.0728 | 0.82 (0.65–1.02) | 0.0744 | 0.8 (0.63–1.02) | 0.0657 |
 Unknown | 0.16 (0.04–0.64) | 0.0098 | 0.39 (0.1–1.6) | 0.1928 | 0.16 (0.05–0.49) | 0.0014 | 0.33 (0.11–1.04) | 0.0592 |
Region | ||||||||
 West | 1 |  | 1 |  | 1 |  | 1 |  |
 South | 1.16 (1.01–1.34) | 0.0397 | 1.22 (1.05–1.42) | 0.01 | 1.16 (1.03–1.3) | 0.0124 | 1.2 (1.06–1.35) | 0.0034 |
 Midwest | 1.38 (1.14–1.67) | 0.0008 | 1.22 (1–1.49) | 0.0478 | 1.29 (1.1–1.51) | 0.0014 | 1.18 (1–1.39) | 0.0475 |
 Northwest | 0.93 (0.79–1.1) | 0.3925 | 1.03 (0.87–1.21) | 0.7785 | 0.98 (0.86–1.12) | 0.7558 | 1.06 (0.93–1.21) | 0.3898 |
CEA | ||||||||
 Negative | 1 |  | 1 |  | 1 |  | 1 |  |
 Positive | 1.82 (1.54–2.15) | <.0001 | 1.4 (1.17–1.67) | 0.0006 | 1.67 (1.45–1.93) | <.0001 | 1.33 (1.14–1.54) | 0.0002 |
 Unknown | 0.53 (0.45–0.61) | <.0001 | 0.97 (0.83–1.14) | 0.7777 | 0.63 (0.55–0.71) | <.0001 | 0.99 (0.87–1.13) | 0.909 |
Deposit | ||||||||
 Negative | 1 |  | 1 |  | 1 |  | 1 |  |
 Positive | 4.21 (3.49–5.07) | <.0001 | 1.31 (1.07–1.6) | 0.008 | 3.36 (2.88–3.92) | <.0001 | 1.36 (1.15–1.61) | 0.0003 |
 Unknown | 1.15 (1–1.32) | 0.0431 | 1.37 (1.19–1.58) | <.0001 | 1.04 (0.93–1.16) | 0.4885 | 1.22 (1.09–1.37) | 0.0007 |
Tumor size | ||||||||
  < 2 cm | 1 |  | 1 |  | 1 |  | 1 |  |
 2–2.9 cm | 3.45 (2.64–4.5) | <.0001 | 1.23 (0.93–1.62) | 0.1461 | 2.18 (1.8–2.65) | <.0001 | 1.12 (0.91–1.38) | 0.2898 |
  ≤ 3 cm | 5.2 (4.2–6.42) | <.0001 | 1.33 (1.06–1.67) | 0.0143 | 3.19 (2.76–3.69) | <.0001 | 1.25 (1.06–1.47) | 0.0085 |
 Unknown | 4.53 (3.64–5.65) | <.0001 | 1.33 (1.06–1.69) | 0.0163 | 2.87 (2.46–3.34) | <.0001 | 1.24 (1.05–1.47) | 0.0132 |
Harvested lymph nodes | ||||||||
  ≤ 12 | 1 |  | 1 |  | 1 |  | 1 |  |
  > 12 | 0.88 (0.78–0.99) | 0.0318 | 0.58 (0.51–0.66) | <.0001 | 0.82 (0.75–0.91) | <.0001 | 0.61 (0.55–0.68) | <.0001 |
 Unknown | 1.76 (1.14–2.72) | 0.0108 | 0.85 (0.55–1.32) | 0.5551 | 1.46 (1–2.12) | 0.0501 | 0.82 (0.56–1.2) | 0.2969 |
Histology | ||||||||
 GCC | 1 |  | 1 |  | 1 |  | 1 |  |
 MAC | 2.39 (1.85–3.09) | <.0001 | 1.31 (0.99–1.74) | 0.0609 | 1.81 (1.5–2.19) | <.0001 | 1.16 (0.94–1.43) | 0.1765 |
 NMAC | 3.59 (2.77–4.67) | <.0001 | 2.26 (1.71–2.99) | <.0001 | 2.91 (2.4–3.53) | <.0001 | 2.05 (1.66–2.53) | <.0001 |
 SRCC | 6.81 (5.16–8.99) | <.0001 | 1.89 (1.4–2.55) | <.0001 | 4.63 (3.75–5.71) | <.0001 | 1.78 (1.41–2.24) | <.0001 |
 NECs | 0.42 (0.23–0.74) | 0.0027 | 0.76 (0.42–1.4) | 0.3776 | 0.63 (0.44–0.89) | 0.0093 | 0.95 (0.65–1.39) | 0.7755 |
 NETs | 0.12 (0.06–0.23) | <.0001 | 0.32 (0.16–0.65) | 0.0017 | 0.35 (0.26–0.48) | <.0001 | 0.64 (0.45–0.92) | 0.0171 |
 MiNENs | 3.03 (2.18–4.2) | <.0001 | 1.72 (1.23–2.41) | 0.0016 | 2.08 (1.61–2.7) | <.0001 | 1.4 (1.07–1.83) | 0.0137 |
T stage | ||||||||
 T1 | 1 |  | 1 |  | 1 |  | 1 |  |
 T2 | 1.54 (0.96–2.46) | 0.0741 | 0.77 (0.47–1.24) | 0.2788 | 1.34 (1.03–1.76) | 0.0327 | 0.79 (0.59–1.05) | 0.1077 |
 T3 | 4.51 (3.32–6.13) | <.0001 | 1.51 (1.08–2.12) | 0.0165 | 2.38 (1.99–2.85) | <.0001 | 1.15 (0.93–1.43) | 0.1923 |
 T4 | 12.72 (9.5–17.02) | <.0001 | 2.38 (1.71–3.32) | <.0001 | 5.2 (4.4–6.15) | <.0001 | 1.69 (1.37–2.09) | <.0001 |
N stage | ||||||||
 N0 | 1 |  | 1 |  | 1 |  | 1 |  |
 N1 | 3.14 (2.72–3.62) | <.0001 | 2.26 (1.93–2.65) | <.0001 | 2.32 (2.06–2.61) | <.0001 | 2 (1.75–2.28) | <.0001 |
 N2 | 8.15 (7.05–9.42) | <.0001 | 3.03 (2.53–3.62) | <.0001 | 5.8 (5.14–6.56) | <.0001 | 2.89 (2.48–3.37) | <.0001 |
M stage | ||||||||
 M0 | 1 |  | 1 |  | 1 |  | 1 |  |
 M1 | 5.46 (4.85–6.16) | <.0001 | 2.45 (2.1–2.86) | <.0001 | 3.47 (3.16–3.81) | <.0001 | 2.04 (1.8–2.31) | <.0001 |
Grade | ||||||||
 Well differentiated | 1 |  | 1 |  | 1 |  | 1 |  |
 Moderately differentiated | 2.83 (2.33–3.44) | <.0001 | 1.62 (1.32–1.99) | <.0001 | 2.32 (2.01–2.67) | <.0001 | 1.49 (1.28–1.73) | <.0001 |
 Poorly or un-differentiated | 8.52 (7.08–10.26) | <.0001 | 2.73 (2.2–3.39) | <.0001 | 5.44 (4.73–6.25) | <.0001 | 2.21 (1.87–2.62) | <.0001 |
 Unknown | 2.53 (2.05–3.11) | <.0001 | 2.16 (1.73–2.69) | <.0001 | 2.08 (1.78–2.42) | <.0001 | 1.71 (1.45–2.02) | <.0001 |
Surgery | ||||||||
 Less than hemicolectomy | 1 |  |  |  | 1 |  | 1 |  |
 Hemicolectomy or more | 1.43 (1.26–1.63) | <.0001 |  |  | 1.22 (1.11–1.35) | <.0001 | 0.89 (0.8–0.98) | 0.024 |
 Other | 2.88 (2.36–3.52) | <.0001 |  |  | 2.16 (1.82–2.56) | <.0001 | 1.51 (1.26–1.81) | <.0001 |
Chemotherapy | ||||||||
 No | 1 |  | 1 |  | 1 |  | 1 |  |
 Yes | 3.54 (3.14–3.99) | <.0001 | 0.93 (0.8–1.07) | 0.2983 | 2.11 (1.93–2.32) | <.0001 | 0.73 (0.65–0.82) | <.0001 |